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Abstract 
Background: Massive liquid crystal droplets have been found during embryonic development in more than twenty 
different tissues and organs, including the liver, brain and kidney. Liquid crystal deposits have also been identified in 
multiple human pathologies, including vascular disease, liver dysfunction, age-related macular degeneration, and 
other chronic illnesses. Despite the involvement of liquid crystals in such a large number of human processes, this 
phenomenon is poorly understood and there are no in vitro systems to further examine the function of liquid crystals 
in biology.
Results: We report the presence of tubular birefringent structures in embryoid bodies (EBs) differentiated in culture. 
These birefringent tubular structures initiate at the EB surface and penetrated the cortex at a variety of depths. Under 
crossed polarized light, these tubules are seen as a collection of birefringent Maltese crosses and tubules with birefrin-
gent walls and a non-birefringent lumen. The fluidity of these birefringent structures under pressure application led 
to elongation and widening, which was partially recoverable with pressure release. These birefringent structures also 
displayed heat triggered phase transition from liquid crystal to isotropic status that is partially recoverable with return 
to ambient temperature. These pressure and temperature triggered changes confirm the birefringent structures as 
liquid crystals. The first report of liquid crystal so early in development.
Conclusion: The structure of the liquid crystal tubule network we observed distributed throughout the differentiated 
embryoid bodies may function as a transportation network for nutrients and metabolic waste during EB growth, and 
act as a precursor to the vascular system. This observation not only reveals the involvement of liquid crystals earlier 
than previously known, but also provides a method for studying liquid crystals in vitro.
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Dear editor
Liquid crystals have been reported in more than 20 
embryonic tissues and organs, including the develop-
ing liver, yolk sac, and blood [1–6]. Further studies have 
proven that hepatic liquid crystals are omnipresent in all 
vertebrate liver during development [5, 7–13]. Despite 
prevalence in organs systems and across species, the 
function of liquid crystals during animal development 
remains unknown. To study liquid crystals earlier in the 
developmental timeline, we developed embryoid bod-
ies (EBs) aggregated from pluripotent cells derived from 
embryonic stem (ES) cells or reprogrammed from adult 
epithelial skin cells or induced pluripotent stem (iPS) 
cells [14–16]. Since EBs are made up of a large variety of 
differentiated cell types growing in a three dimensional 
space, they are considered a valuable model system for 
investigating cellular and molecular interactions dur-
ing the earliest stages of development. Because EB cells 
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are precursors to the full spectrum of cell types needed 
to repair damaged tissue, better understanding of them 
offers great promise in clinical application. The most 
interesting of these applications is the potential of the 
EB system as a drug screening platform for multiple dis-
eases, including heart disease, cancer, and other chronic 
illnesses [1, 17–21].
In this study, we report the unexpected presence of 
liquid crystals in EBs aggregated from embryonic stem 
cells. Systematic characterization of these birefringent 
liquid crystals show these complexes to be distributed 
throughout the EB as a network of tubules. The contours 
of these tubular liquid crystal tubes resemble the vascu-
lar network within the human body, linking the outside 
environment to the EB interior. Due to this structure, we 
postulate that liquid crystals may function as a transpor-
tation network for nutrients and metabolic waste during 
EB growth. By revealing the possible function of liquid 
crystals as the “highway” of the EB cluster, our findings 
provide valuable information towards understanding 
the function of liquid crystals in animal development 
and reveal their role in establishing a possible mode 
of communication between a tissue and the external 
environment.
Birefringent droplets and tubular structure 
complex form in differentiated EB spheres
To investigate the function of liquid crystals, we utilized 
the human embryonic stem cell H9 and induced pluripo-
tent stem cells (iPS DF19-9-7T) to carry out embryoid 
body aggregation. Stem cells were seeded and maintained 
in mTeSR-1 media as previously described (Additional 
file  1: Figure S1). The ES cell clumps were cultured on 
low attachment Petri dishes coated with 0.1% gelatin. H9 
and DF19-9-7T were maintained on culture plates coated 
with Matrigel (StemCell Technology) and cultured in 
mTeSR-1 media. After cell clumps have aggregated, EBs 
were allowed to grow for 8 weeks and form differentiated 
spheres. These EB differentiated spheres were then har-
vested and cryosectioned at the thickness of 10  μm for 
observations under polarization microscope. Oct-3/4 
expression in these samples was detected using cyto-
chemistry and RT-PCR conducted as detailed in Addi-
tional file 1: Figure S1.
Observation of EB spheres under polarization micro-
scope revealed unexpected birefringent structures not 
identifiable through hematoxylin and eosin (H&E) histol-
ogy (Fig. 1a–c) with standard method [22–25]. The overall 
shapes of these birefringent structures were droplet-like 
and tubular. They originated at the EB sphere surface and 
tunneled deeper into cortex, with the highest density of 
tubes observed near the EB periphery. These liquid crystal 
complexes begin with clusters of two or three birefringent 
droplets located just within the outer surface and distrib-
uted ~35 μm apart (Fig. 1d). Tubules from these birefrin-
gent clusters penetrate towards the cortex to a variety of 
depths (Fig. 1a–h). While most of these structures termi-
nate before reaching the center of the EB (Fig. 1f–j), some 
birefringent tubules penetrate the entire cell cluster until 
reaching the core of the sphere (Fig.  1h). Under crossed 
polarized light, these liquid crystal tubules present as a 
collection of birefringent droplets in the shape of Maltese 
crosses and tubules with birefringent shell-like walls and a 
non-birefringent lumen (Fig. 1e–h). The Maltese crosses 
are cross sectioned images of the tubules while the clearly 
tubular birefringence are these same structures caught 
in longitudinal section. The lengths of these tubules vary 
from 40  μm to 2  mm, while the diameters consistently 
measured between 20 and 60 μm (Fig. 2a, c). The thick-
ness of the tubular wall, as defined by the birefringence 
of the “shell”, measured at 4 and 9 μm for the longitudi-
nal and cross-sectional images, respectively (Fig.  2b, c). 
This difference in thickness, as defined by birefringence, is 
logical given that cross sectional slices along a tube would 
lead to a thicker deposit of birefringent material, which in 
turn causes the brighter birefringence that measures as a 
thicker wall.
Fluidity of birefringent structures in differentiated 
EBs
To characterize liquid crystal fluidity of the birefringent 
structures, pressure-recovery experiments were con-
ducted on the EB smear samples. Following previously 
described protocol, pressure was applied evenly on the 
cover-glass with a rubber applicator and measurements 
of its effect on the birefringent structures were made 
between crossed polarized light and analyzed via ImageJ. 
Documentations on distances and density were based on 
birefringence of the Maltese cross and tubule structure 
[6].
After pressure was applied, the birefringent structures 
were distorted into elongated tubules (Fig. 3a, d). Com-
pared to before the pressure application (Fig. 3b), flatten-
ing of the liquid crystal tubules under pressure lead to an 
enlarged birefringent complex (from Fig. 3c). This distor-
tion in tubular length and width is quantified in Fig. 3d. 
Time lapse images from a single tubule in Fig.  3e–m 
demonstrate the tubule distortion and partial recov-
ery after pressure application. This recovery requires 
approximately 60–90  min, depending on the size of the 
birefringent tubule. The flexibility of birefringent tubules 
leads to a variety of recovery shapes and processes. From 
the movement and characteristics documented above, 
we conclude that the EBs birefringent tubular structures 
have the fluidity and birefringence activity typical of liq-
uid crystal.
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Fig. 1 The birefringent structures in the embryoid bodies derived from H9 and induced iPS DF19-9-7T) at 8-weeks after differentiation. The liquid 
crystal birefringence distribution in the cortex region (CR) of the EB in (a) and sketched (b) compared to H&E histology (c). The structures of the 
birefringence are mainly tubular or droplet shaped with the wider-ends oriented towards the center of the EB (d). Arrows in d denote the indi-
vidual ~35 μm spaced birefringent clusters from which liquid crystal tubules originate on the EB surface. Cross sectional cut exposing the tubular 
structures (e). The birefringence distributions in two representative cortex areas of an EB (f, g) and their respective quantifications (i, j). Representa-
tive image showing the trajectory of a tubule penetrating to the EB core when cut along the longitudinal axis (h). The scale bars are 60 μm in a and 
c and 300 μm in d–h
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Liquid crystal characteristics confirmed in EB 
structures during temperature phase transition 
experiments
The droplet and tubular liquid crystals (D/T-LC) identi-
fied in differentiated EB spheres have thus far exhibited 
the birefringence and pressure recovery characteristics 
typical of true liquid crystals. Here we demonstrate that 
the birefringent D/T-LC structures also conform to the 
temperature-sensitive phase transitional properties typi-
cal of liquid crystals.
Using temperature alternations generated by a thermo-
stage, we show that D/T-LC structures phase transition 
from liquid crystal status to isotropic status when the 
temperature is increased to 43 °C. This process is partially 
reversible when ambient temperature is restored. This tran-
sition is seen as disappearing birefringence with tempera-
ture increase (Fig. 4a–g) and partial birefringence recovery 
(Fig. 4h, i). This effect is dramatic and quantifiable in Fig. 4j. 
A higher magnification of the D/T-LC structures before and 
after temperature-transition is shown to demonstrate the 
incomplete recovery of liquid crystal structure (Fig.  4k, l). 
Quantification of birefringent structures show that recovery 
from the isotropic state results in significant smaller Maltese 
crosses (Fig. 4m). Evenly distributed fragments of birefrin-
gent droplet were also documented in these post-tempera-
ture change EB (indicated by arrow heads).
The tubular liquid crystal structure is an extremely flex-
ible entity capable of assuming different forms. Tempera-
ture is key to increasing the malleability of liquid crystals. 
When the temperature is raised, the tubular structure 
breaks into fragments. As seen in our experiments, these 
fragmented liquid crystal tubules retain their liquid crys-
tal optical properties, but take the form of easily manipu-
lated droplets (Fig.  4l, m). This thermal triggered phase 
transition and structural flexibility is typical property 
of liquid crystals and can be easily taken advantage of 
in vivo. By generating local temperature changes, tissues 
can increase the malleability of liquid crystals and reform 
Fig. 2 Distribution of the longitudinal and cross sections of the EB tubular liquid crystal structures. Quantified measurements of longitudinal and 
cross sectional diameter lengths (a). Quantified thickness measurements of the shell-like wall (b). All measurements were obtained from birefrin-
gence of multiple cross sectional and longitudinal sections (For longitudinal diameters D1 and D2, n = 24; For cross diameters D1 and D2, n = 24; 
For longitudinal and cross sections, wall-thickness W1 and W2, n = 23). The diameter measurement is obtained from the distance between the 
outer edges of both sides of the birefringence along the long and short axis. Wall measurements are defined as the average width of the birefrin-
gence on each side of the axis (c)
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them to suit the desired function. The cortical EB liquid 
crystal tubules are always accompanied by Maltese-cross 
droplets and could be evidence of this supposition (Fig. 1).
Liquid crystals have long been found in the developing 
vital organs of a wide range of animals [4, 6, 26, 27]. Liq-
uid crystals have also been reported in human vascular 
disease, liver dysfunction, age-related macular degen-
eration, and other chronic illnesses [28–36]. Given the 
pervasiveness of liquid crystals from embryogenesis to 
disease, identifying the function and underlying molecu-
lar mechanism of liquid crystals would lend great insight 
to a diverse set of cellular processes. However, the spe-
cific mechanism and function of liquid crystals during 
embryogenesis and illness remains unknown. This con-
tinuing mystery can be contributed to the complexity of 
embryonic development and the difficulties in simulating 
embryonic development in vivo.
Embryonic stem cells can differentiate into 250 cell-
types required for constructing the entire repertoire of 
mammalian tissues and organs. Since all of these tis-
sues develop after EB formation, the EB culture sys-
tem is a model that allows researchers to investigate 
stem cell application in human diseases. Using this 
approach, we have unexpectedly discovered the exist-
ence of droplet and tubular liquid crystals in EB. These 
tubular complexes initiate at the embryoid body surface 
and are found throughout the cortex. Although most 
of the tubules remain near the cortical surface, some of 
the structures penetrate to the heart of the EB. Based 
on our results, we postulate that the formation of D/T-
LC results in a three-dimensional “vascular” system 
that allows transport of nutrients and metabolic waste 
throughout the EB. Since a greater number of cells reside 
in the outer layers, this may explain the prevalence of 
LC tubules near the EB surface where more tubules are 
needed to ensure each cell receives adequate nutrients. 
However, the mechanisms for recognition and distri-
bution of nutrients and waste through this D/T-LC 
Fig. 3 Fluidity characterization of the liquid crystal structures in embryoid bodies derived from H9 and induced iPS DF19-9-7T using the pressure 
application and release approach. The structures exhibited elongation after pressure application (a). The birefringent complex structures were 
spread and flattened (c) compared to the structures prior to pressure application (b) in the same view. This change in width was insignificant (d). 
Time elapse images of the birefringent tubular structure before (e) and after pressure application (f–k) documents the structural distortion and 
recovery. Higher magnification images of liquid crystal tube recovery and quantifications of width distortion and recovery in several different 
tubules are shown (l and m, respectively). Statistical significance of tubule width changes in T2–T7 of panel m references time point 1 (T1) of respec-
tive color-coded tubules P1–P4. *p < 0.05 and **p < 0.01 in panel m. Scale bars 300 μm in (a); 60 μm in b and c; 120 μm in e–k
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system requires further exploration. The EB culture 
and differentiation approach developed here is an ideal 
in vitro model system for exploring liquid crystal func-
tion in embryogenesis and disease. Understanding of 
liquid crystal function in embryogenesis will not only 
shed light on a previously unknown aspect of develop-
ment, but may also lead to pharmacological advances by 
unveiling new pathways through which we can penetrate 
tightly packed cell clusters, such as difficult to access 
tumor interiors.
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